Role of Microenvironment in Resistance to Therapy in AML

Overview

Journal Curr Hematol Malig Rep

Publisher Current Science

Specialties Hematology
Oncology

Date 2015 Apr 30

PMID 25921386

Citations 56

Authors

Yoko Tabe

Marina Konopleva

Affiliations

Soon will be listed here.

Abstract

As part of the dynamic interactions between leukemic cells and cells of the bone marrow microenvironment, specific niches provide a sanctuary where subpopulations of leukemic cells evade chemotherapy-induced death and acquire a drug-resistant phenotype. This review focuses on the cellular and molecular biology of the leukemia stem cell (LSC) niche and of microenvironment/leukemia interactions. Key emerging therapeutic targets include chemokine receptors, adhesion molecules, the sympathetic nervous system, and hypoxia-related proteins, as well as the genetic and epigenetic abnormalities of the leukemia-associated stroma. The complex interplay between LSCs and microenvironment components provides a rationale for appropriately tailored molecular therapies designed to improve outcomes in leukemia. Further understanding of the contribution of the bone marrow niche to the process of leukemogenesis may provide new targets that allow destruction of LSCs without adversely affecting normal stem cell self-renewal.

Citing Articles

CX43-mediated mitochondrial transfer maintains stemness of KG-1a leukemia stem cells through metabolic remodeling.

Fu H, Xie X, Zhai L, Liu Y, Tang Y, He S Stem Cell Res Ther. 2024; 15(1):460.

PMID: 39623456 PMC: 11613858. DOI: 10.1186/s13287-024-04079-3.

The KIR2DL family serves as prognostic biomarkers and correlates with immune infiltrates in acute myeloid leukaemia.

Liu W, Zhu M, Li G, Xi Y J Cell Mol Med. 2024; 28(8):e18256.

PMID: 38527290 PMC: 10963068. DOI: 10.1111/jcmm.18256.

The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients.

Park M Int J Mol Sci. 2023; 24(15).

PMID: 37569414 PMC: 10418941. DOI: 10.3390/ijms241512037.

Identifying prognostic biomarker related to immune infiltration in acute myeloid leukemia.

Lu W, Yu G, Li Y, Yin C, Long J, Chen X Clin Exp Med. 2023; 23(8):4553-4562.

PMID: 37561221 DOI: 10.1007/s10238-023-01164-4.

Comprehensive bioinformatic analysis of the expression and prognostic significance of TSC22D domain family genes in adult acute myeloid leukemia.

Xu X, Sun R, Li Y, Wang J, Zhang M, Xiong X BMC Med Genomics. 2023; 16(1):117.

PMID: 37237254 PMC: 10224341. DOI: 10.1186/s12920-023-01550-7.

References

Nervi B, Ramirez P, Rettig M, Uy G, Holt M, Ritchey J . Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood. 2008; 113(24):6206-14. PMC: 2699239. DOI: 10.1182/blood-2008-06-162123. View

Arranz A, Delbroek L, Van Kolen K, Guimaraes M, Mandemakers W, Daneels G . LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism. J Cell Sci. 2014; 128(3):541–52. DOI: 10.1242/jcs.158196. View

Ceradini D, Kulkarni A, Callaghan M, Tepper O, Bastidas N, Kleinman M . Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10(8):858-64. DOI: 10.1038/nm1075. View

Hartwell K, Miller P, Mukherjee S, Kahn A, Stewart A, Logan D . Niche-based screening identifies small-molecule inhibitors of leukemia stem cells. Nat Chem Biol. 2013; 9(12):840-848. PMC: 4009363. DOI: 10.1038/nchembio.1367. View

Katayama Y, Battista M, Kao W, Hidalgo A, Peired A, Thomas S . Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell. 2006; 124(2):407-21. DOI: 10.1016/j.cell.2005.10.041. View

Duhrsen U, Hossfeld D . Stromal abnormalities in neoplastic bone marrow diseases. Ann Hematol. 1996; 73(2):53-70. DOI: 10.1007/s002770050203. View

Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K . Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004; 118(2):149-61. DOI: 10.1016/j.cell.2004.07.004. View

Jin L, Hope K, Zhai Q, Smadja-Joffe F, Dick J . Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006; 12(10):1167-74. DOI: 10.1038/nm1483. View

Doan P, Chute J . The vascular niche: home for normal and malignant hematopoietic stem cells. Leukemia. 2011; 26(1):54-62. DOI: 10.1038/leu.2011.236. View

10.

Williams K, Motiani K, Giridhar P, Kasper S . CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches. Exp Biol Med (Maywood). 2013; 238(3):324-38. PMC: 11037417. DOI: 10.1177/1535370213480714. View

11.

Kiel M, Morrison S . Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol. 2008; 8(4):290-301. DOI: 10.1038/nri2279. View

12.

Rombouts E, Pavic B, Lowenberg B, Ploemacher R . Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia. Blood. 2004; 104(2):550-7. DOI: 10.1182/blood-2004-02-0566. View

13.

Adams G, Chabner K, Alley I, Olson D, Szczepiorkowski Z, Poznansky M . Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature. 2005; 439(7076):599-603. DOI: 10.1038/nature04247. View

14.

Kuhne M, Mulvey T, Belanger B, Chen S, Pan C, Chong C . BMS-936564/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies. Clin Cancer Res. 2012; 19(2):357-66. DOI: 10.1158/1078-0432.CCR-12-2333. View

15.

Balooch G, Balooch M, Nalla R, Schilling S, Filvaroff E, Marshall G . TGF-beta regulates the mechanical properties and composition of bone matrix. Proc Natl Acad Sci U S A. 2005; 102(52):18813-8. PMC: 1323171. DOI: 10.1073/pnas.0507417102. View

16.

Simsek T, Kocabas F, Zheng J, DeBerardinis R, Mahmoud A, Olson E . The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell. 2010; 7(3):380-90. PMC: 4159713. DOI: 10.1016/j.stem.2010.07.011. View

17.

Schofield R . The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells. 1978; 4(1-2):7-25. View

18.

Calvi L, Adams G, Weibrecht K, Weber J, Olson D, Knight M . Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003; 425(6960):841-6. DOI: 10.1038/nature02040. View

19.

Sison E, Mcintyre E, Magoon D, Brown P . Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML. Mol Cancer Res. 2013; 11(9):1004-16. PMC: 3778118. DOI: 10.1158/1541-7786.MCR-13-0114. View

20.

Rupec R, Jundt F, Rebholz B, Eckelt B, Weindl G, Herzinger T . Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. Immunity. 2005; 22(4):479-91. DOI: 10.1016/j.immuni.2005.02.009. View